Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-host Disease Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Temporarily pausedNCT03467386
What this trial is testing

Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
City of Hope Medical Center 56
Not applicableLooking for participantsNCT03555851
What this trial is testing

Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy

Who this might be right for
Leukemia, Not Otherwise SpecifiedLeukemia, Other
Wake Forest University Health Sciences 120
Testing effectiveness (Phase 2)UnknownNCT04688021
What this trial is testing

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Who this might be right for
LeukemiaGraft-versus-host-disease
Yi Luo 46
Testing effectiveness (Phase 2)Study completedNCT00201799
What this trial is testing

Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft-Versus-Host Disease
Ohio State University Comprehensive Cancer Center 19
Large-scale testing (Phase 3)Active Not RecruitingNCT05153226
What this trial is testing

GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG

Who this might be right for
Graft Vs Host DiseasePeripheral Blood Stem Cell TransplantationAML+3 more
DKMS gemeinnützige GmbH 640
Testing effectiveness (Phase 2)UnknownNCT02478424
What this trial is testing

Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease

Who this might be right for
Graft vs Host Disease
Rabin Medical Center 10
Large-scale testing (Phase 3)Study completedNCT00180089
What this trial is testing

Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation

Who this might be right for
LeukemiaGraft-Versus-Host Disease
Technische Universität Dresden 242
Testing effectiveness (Phase 2)Study completedNCT03700450
What this trial is testing

Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 37
Testing effectiveness (Phase 2)UnknownNCT03225417
What this trial is testing

Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.

Who this might be right for
Hematopoietic Stem Cell TransplantationMultiple Myeloma
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 142
Large-scale testing (Phase 3)Study completedNCT00678275
What this trial is testing

Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Universitätsklinikum Hamburg-Eppendorf 161
Testing effectiveness (Phase 2)Study completedNCT03680092
What this trial is testing

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

Who this might be right for
GVHDHematologic Neoplasms
Dimitrios Tzachanis, MD PhD 43
Testing effectiveness (Phase 2)UnknownNCT00524784
What this trial is testing

Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD

Who this might be right for
Graft Versus Host DiseaseHematological Malignancies
Hadassah Medical Organization 12
Early research (Phase 1)Study completedNCT02867800
What this trial is testing

Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseGraft Versus Host Disease
Monica Bhatia 24
Early research (Phase 1)Looking for participantsNCT06996119
What this trial is testing

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaGraft Versus Host DiseaseMyelodysplastic Syndrome
City of Hope Medical Center 15
Testing effectiveness (Phase 2)UnknownNCT05969743
What this trial is testing

Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host Disease

Who this might be right for
Graft-versus-host-diseaseCMV
Rabin Medical Center 42
Large-scale testing (Phase 3)Ended earlyNCT00003056
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaGraft Versus Host Disease
Baxalta now part of Shire 105
Testing effectiveness (Phase 2)Study completedNCT02145403
What this trial is testing

Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesRelapseGraft-Versus-Host Disease
University of Michigan Rogel Cancer Center 53
Early research (Phase 1)Ended earlyNCT01663766
What this trial is testing

Phase I Study of Milatuzumab for Graft Versus Host Disease

Who this might be right for
GVHD (Acute or Chronic)Acute Myeloid or Lymphoblastic Leukemia (AML or ALL)Myelodysplastic Syndrome+4 more
Gilead Sciences 12
Large-scale testing (Phase 3)Looking for participantsNCT06705062
What this trial is testing

Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Cell TransplantGraft Versus Host Disease
Shanghai Jiao Tong University School of Medicine 316
Large-scale testing (Phase 3)Study completedNCT00382109
What this trial is testing

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

Who this might be right for
B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionGraft Versus Host Disease+3 more
Children's Oncology Group 146
Next Page